0001562180-18-003237.txt : 20180705
0001562180-18-003237.hdr.sgml : 20180705
20180705152133
ACCESSION NUMBER: 0001562180-18-003237
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180705
FILED AS OF DATE: 20180705
DATE AS OF CHANGE: 20180705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moses Jennifer K.
CENTRAL INDEX KEY: 0001706667
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 18940479
MAIL ADDRESS:
STREET 1: 79 TW ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: P. O. BOX # 110341
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2018-07-05
false
0001560241
G1 Therapeutics, Inc.
GTHX
0001706667
Moses Jennifer K.
C/O G1 THERAPEUTICS, 79 TW ALEXANDER DR.
4501 RESEARCH COMMONS, SUITE 100
RESEARCH TRIANGLE PARK
NC
27709
false
true
false
false
VP of Finance & Admin
Common Stock
2018-07-05
4
M
false
750.00
0.39
A
750.00
D
Common Stock
2018-07-05
4
S
false
750.00
45.66
D
0.00
D
Stock Options (Right to Buy)
0.39
2018-07-05
4
M
false
750.00
0.00
D
2024-07-11
Common Stock
750.00
5416.00
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
All shares underlying this option have vested
/s/ Peter N. Cunningham, attorney-in-fact
2018-07-05